• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.

作者信息

Brumfiel Caitlin M, Patel Meera H, DiCaudo David J, Rosenthal Allison C, Pittelkow Mark R, Mangold Aaron R

机构信息

Department of Dermatology, Mayo Clinic Arizona, Scottsdale, USA.

Department of Medicine, Division Hematology-Oncology, Phoenix, USA.

出版信息

Leuk Lymphoma. 2021 Oct;62(10):2554-2555. doi: 10.1080/10428194.2021.1924371. Epub 2021 May 11.

DOI:10.1080/10428194.2021.1924371
PMID:33974494
Abstract
摘要

相似文献

1
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后原发性皮肤CD30阳性淋巴增殖性疾病复发
Leuk Lymphoma. 2021 Oct;62(10):2554-2555. doi: 10.1080/10428194.2021.1924371. Epub 2021 May 11.
2
Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes.接种 COVID-19 疫苗后的皮肤淋巴组织增生性疾病：临床表现、组织病理学和结局。
Leuk Lymphoma. 2024 Jan;65(1):48-54. doi: 10.1080/10428194.2023.2270766. Epub 2024 Jan 10.
3
Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: A reactive lymphomatoid papulosis-like eruption and a bona fide lymphoma.两例具有挑战性的皮肤淋巴组织浸润病例，发生于 COVID-19 疫苗接种背景下：反应性蕈样肉芽肿样疹和真性淋巴瘤。
J Cutan Pathol. 2023 Mar;50(3):213-219. doi: 10.1111/cup.14371. Epub 2022 Dec 13.
4
CD30-Positive Lymphoproliferative Disorders.CD30 阳性淋巴增殖性疾病
Cancer Treat Res. 2019;176:249-268. doi: 10.1007/978-3-319-99716-2_12.
5
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.原发性皮肤CD30（Ki-1）阳性淋巴增殖性疾病谱。分类建议及管理与治疗指南。
J Am Acad Dermatol. 1993 Jun;28(6):973-80. doi: 10.1016/0190-9622(93)70140-o.
6
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.CD30阳性淋巴增殖性疾病——来自彼得·麦卡勒姆癌症中心的澳大利亚临床实践声明
Australas J Dermatol. 2023 May;64(2):194-203. doi: 10.1111/ajd.14016. Epub 2023 Mar 9.
7
[Primary cutaneous CD30-positive T-cell lymphoproliferative disorders:report of a case].
Zhonghua Bing Li Xue Za Zhi. 2021 Jun 8;50(6):673-675. doi: 10.3760/cma.j.cn112151-20200924-00744.
8
Pathology case of the month. A recurrent vesicle on the plantar aspect of the foot. Primary cutaneous CD30- positive T-cell lymphoproliferative disorder, consistent with lymphomatoid papulosis.本月病理病例。足底反复出现水疱。原发性皮肤CD30阳性T细胞淋巴增殖性疾病，符合淋巴瘤样丘疹病。
J La State Med Soc. 2004 Jan-Feb;156(1):15-8.
9
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.CD30 阳性原发性皮肤淋巴组织增生性疾病：分子改变与靶向治疗。
Haematologica. 2019 Feb;104(2):226-235. doi: 10.3324/haematol.2018.197152. Epub 2019 Jan 10.
10
Primary cutaneous CD30(+) lymphoproliferative disorders.原发性皮肤CD30(+)淋巴增殖性疾病
J Dtsch Dermatol Ges. 2016 Aug;14(8):767-82. doi: 10.1111/ddg.13117.

引用本文的文献

1
Rapid Progression of Cutaneous Lymphoma Following mRNA COVID-19 Vaccination: A Case Report and Pathogenetic Insights.mRNA新冠疫苗接种后皮肤淋巴瘤的快速进展：一例报告及发病机制见解
Vaccines (Basel). 2025 Jun 25;13(7):678. doi: 10.3390/vaccines13070678.
2
Cutaneous Pseudolymphoma after COVID-19 Vaccine Injection.新冠疫苗注射后出现的皮肤假性淋巴瘤。
Indian J Dermatol. 2024 May-Jun;69(3):269-272. doi: 10.4103/ijd.ijd_420_22. Epub 2024 Jun 26.
3
Exploring cutaneous lymphoproliferative disorders in the wake of COVID-19 vaccination.
探索新冠病毒疫苗接种后的皮肤淋巴增殖性疾病
Skin Health Dis. 2024 Mar 25;4(3):e367. doi: 10.1002/ski2.367. eCollection 2024 Jun.
4
Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review.罕见的新冠疫苗副作用在混乱中被忽视了。新冠疫苗接种后的原发性皮肤淋巴瘤：一项系统综述。
Front Med (Lausanne). 2024 Apr 10;11:1325478. doi: 10.3389/fmed.2024.1325478. eCollection 2024.
5
Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature.新冠疫苗接种后原发性皮肤CD4小/中型T细胞淋巴增殖性疾病——关于新冠疫苗接种后淋巴增殖性疾病和皮肤淋巴瘤我们了解多少？1例非典型病例报告及文献综述
Life (Basel). 2024 Mar 14;14(3):386. doi: 10.3390/life14030386.
6
An 82-year-old man with new skin lesions after COVID-19 vaccination.一位 82 岁的男性，在接种 COVID-19 疫苗后出现新的皮肤损伤。
Allergy Asthma Proc. 2024 Jan 1;45(1):70-73. doi: 10.2500/aap.2024.45.230062.
7
Kaempferol: A Review of Current Evidence of Its Antiviral Potential.山奈酚：其抗病毒潜力的当前证据综述。
Int J Mol Sci. 2023 Nov 14;24(22):16299. doi: 10.3390/ijms242216299.
8
B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report.BALB/c小鼠静脉注射BNT162b2 mRNA加强针后发生的B细胞淋巴母细胞淋巴瘤：一例报告。
Front Oncol. 2023 May 1;13:1158124. doi: 10.3389/fonc.2023.1158124. eCollection 2023.
9
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.左手臂接种 BNT162b2 mRNA COVID-19 疫苗后新诊断的左手臂结外 NK/T 细胞淋巴瘤，鼻型。
Int J Hematol. 2023 Oct;118(4):503-507. doi: 10.1007/s12185-023-03607-w. Epub 2023 Apr 24.
10
Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review.血液系统恶性肿瘤患者对新冠疫苗接种的免疫反应：一篇综述
Chonnam Med J. 2023 Jan;59(1):24-30. doi: 10.4068/cmj.2023.59.1.24. Epub 2023 Jan 25.